organophosphonates has been researched along with Seizures in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Georgieva, S; Peneva, P; Rangelov, M; Tchekalarova, J; Todorov, P; Todorova, N | 1 |
| Al-Badri, H; Chapman, AG; Cordi, AA; Desos, P; Fugier, C; Lestage, P; Meldrum, BS; Roger, A; Ruano, E; Thomas, JY | 1 |
| BALES, PD; HIMWICH, HE; JOHNS, RJ | 1 |
| Doerries, R; Drechsler, H; Gass, A; Hardmeier, M; Kuhle, J; Mehling, M; Ruegg, S | 1 |
| Hoshino, S; Iwata, Y; Kittaka, H; Mori, N; Osonoe, K; Osonoe, M; Yamada, Y | 1 |
| Kabuto, H; Shimada, M; Yokoi, I | 1 |
6 other study(ies) available for organophosphonates and Seizures
| Article | Year |
|---|---|
Synthesis, characterization and anticonvulsant activity of new series of N-modified analogues of VV-hemorphin-5 with aminophosphonate moiety.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Hemoglobins; Male; Mice; Mice, Inbred ICR; Molecular Docking Simulation; Organophosphonates; Peptide Fragments; Receptors, Opioid, kappa; Seizures; Solid-Phase Synthesis Techniques; Structure-Activity Relationship | 2019 |
Novel quinolinone-phosphonic acid AMPA antagonists devoid of nephrotoxicity.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analysis of Variance; Animals; Anticonvulsants; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Kidney; Mice; Mice, Inbred DBA; Oocytes; Organophosphonates; Quinolones; Rats; Rats, Inbred F344; Seizures; Structure-Activity Relationship; Sulfonamides; Xenopus | 2002 |
The effects of DFP on the convulsant dose of theophylline, theophylline-ethylenediamine and 8-chlorotheophylline.
Topics: Aminophylline; Convulsants; Humans; Isoflurophate; Organophosphonates; Phosphorous Acids; Seizures; Theophylline; Xanthines | 1951 |
Adaptation of antiretroviral therapy in human immunodeficiency virus infection with central nervous system involvement.
Topics: Adenine; Adult; AIDS Dementia Complex; Alkynes; Anti-HIV Agents; Anticonvulsants; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzoxazines; Cerebrospinal Fluid; Cyclopropanes; Didanosine; HIV-1; Humans; Indinavir; Lamivudine; Male; Nelfinavir; Nevirapine; Oligopeptides; Organophosphonates; Pyridines; Ritonavir; Seizures; Stavudine; Tenofovir; Viral Load; Virus Replication; Zidovudine | 2008 |
The effects of N-methyl-D-aspartate (NMDA) and its competitive antagonist, 3-(2-carboxypiperazine-4-yl)propyl-1-phosphonic acid (CPP), injected into caudate-putamen on kindled amygdaloid seizures in rats.
Topics: Amygdala; Animals; Caudate Nucleus; Electroencephalography; Kindling, Neurologic; Male; N-Methylaspartate; Organophosphonates; Putamen; Rats; Rats, Wistar; Seizures | 1996 |
The effect of omega-phosphono-alpha-aminocarboxylic acids on seizures and brain amino acid levels in E1 mice.
Topics: Amino Acids; Animals; Anticonvulsants; Brain; Convulsants; Female; Hypnotics and Sedatives; Male; Mice; Mice, Inbred Strains; Organophosphonates; Seizures | 1987 |